Related Experiment Video

Updated: Aug 16, 2026

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

Cystic fibrosis-associated liver disease: a population-based study

Katie Corbett1, Suzanne Kelleher, Marion Rowland

  • 1Department of Paediatrics and Children's Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Crumlin, Dublin 12, Ireland.

The Journal of Pediatrics
|September 3, 2004
PubMed

Insights

Children with cystic fibrosis-associated liver disease (CFALD) show impaired growth, nutrition, and lung function. Later diagnosis of cystic fibrosis (CF) is linked to CFALD development.

Area of Science:

  • Pediatric Hepatology
  • Cystic Fibrosis Research
  • Clinical Medicine

Background:

  • Cystic Fibrosis-Associated Liver Disease (CFALD) affects a subset of pediatric cystic fibrosis (CF) patients.
  • Understanding the clinical factors contributing to CFALD is crucial for early intervention and improved patient outcomes.

Purpose of the Study:

  • To identify and explore clinical factors associated with the development of CFALD in children.
  • To compare clinical characteristics between children with CFALD and those with CF but without liver disease.

Main Methods:

  • A case-control study was conducted in the Republic of Ireland from 1999-2000.
  • 42 children (5-18 years) with clinically overt CFALD were pair-matched with CF patients without liver disease.
  • Data on lung function, growth parameters, and diagnostic history were collected.

Main Results:

  • Children with CFALD exhibited significantly lower height, weight, and mid-upper arm circumference compared to controls.
  • Worse forced expiratory volume in 1 second (FEV1) values were observed in the CFALD group.
  • A later age of CF diagnosis and a lower incidence of meconium ileus were noted in children with CFALD.

Conclusions:

  • Established CFALD in children is characterized by impaired growth, nutritional deficits, and compromised lung function (FEV1).
  • Delayed diagnosis of cystic fibrosis is a significant clinical factor associated with the development of CFALD.
Abstract

More Related Videos

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...